FEBS Letters
Artificial miRNAs derived from miR‐181 family members have potential in cancer therapy due to an altered spectrum of target mRNAs
FEBS Letters, Volume 597, Issue 15, Page 1989-2005, August 2023.
FEBS Letters
Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitor
FEBS Letters, Volume 597, Issue 16, Page 2119-2132, August 2023.
FEBS Letters
Defective mitochondrial import as a challenge for cellular protein homeostasis
FEBS Letters, Volume 597, Issue 12, Page 1555-1568, June 2023.
FEBS Letters
ER‐to‐lysosome‐associated degradation in a nutshell: mammalian, yeast, and plant ER‐phagy as induced by misfolded proteins
FEBS Letters, Volume 597, Issue 15, Page 1928-1945, August 2023.
FEBS Letters
FK506‐binding protein 5 regulates cell quiescence‐proliferation decision in zebrafish epithelium
FEBS Letters, Volume 597, Issue 14, Page 1868-1879, July 2023.
FEBS Letters
The FGFR inhibitor PD173074 binds to the C‐terminus of oncofetal HMGA2 and modulates its DNA‐binding and transcriptional activation functions
FEBS Letters, Volume 597, Issue 15, Page 1977-1988, August 2023.
FEBS Letters
Membrane association of the ATG8 conjugation machinery emerges as a key regulatory feature for autophagosome biogenesis
FEBS Letters, Volume 598, Issue 1, Page 107-113, January 2024.
FEBS Letters
Mechanistic insights into the ROS‐mediated inactivation of human aldehyde oxidase
FEBS Letters, Volume 597, Issue 13, Page 1792-1801, July 2023.
FEBS Letters
Cytochrome c oxidase biogenesis – from translation to early assembly of the core subunit COX1
FEBS Letters, Volume 597, Issue 12, Page 1569-1578, June 2023.
FEBS Letters
Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases
FEBS Letters, Volume 597, Issue 11, Page 1489-1502, June 2023.